Dr Reddys Laboratories Ltd
NSE :DRREDDY BSE :500124 Sector : PharmaceuticalsBuy, Sell or Hold DRREDDY? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
22 Nov 1214.45 (1.60%) | 21 Nov 1195.35 (-1.49%) | 19 Nov 1213.45 (1.67%) | 18 Nov 1193.55 (-2.70%) | 14 Nov 1226.70 (-1.47%) | 13 Nov 1245.00 (-1.50%) | 12 Nov 1263.90 (-1.86%) | 11 Nov 1287.90 (0.33%) | 08 Nov 1283.65 (-0.29%) | 07 Nov 1287.35 (-1.13%) | 06 Nov 1302.10 (2.35%) | 05 Nov 1272.20 (0.31%) | 04 Nov 1268.30 (0.69%) | 01 Nov 1259.60 (-1.15%) | 31 Oct 1274.20 (1.95%) | 30 Oct 1249.85 (-1.95%) | 29 Oct 1274.70 (-2.81%) | 28 Oct 1311.50 (0.66%) | 25 Oct 1302.94 (-1.03%) | 24 Oct 1316.54 (-0.38%) | 23 Oct 1321.58 (-0.82%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Bearish
Medium Term Investors
Very Bearish
Long Term Investors
Neutral
Moving Averages
5 DMA
Bullish
1208.36
10 DMA
Bearish
1240.78
20 DMA
Bearish
1262.06
50 DMA
Bearish
1303.82
100 DMA
Bearish
1330.36
200 DMA
Bearish
1277.57
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Nov 22, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1256.84 | 1240.02 | 1222.59 | - | - |
R2 | 1240.02 | 1228.71 | 1219.88 | 1241.03 | - |
R1 | 1227.24 | 1221.73 | 1217.16 | 1229.26 | 1233.63 |
P | 1210.42 | 1210.42 | 1210.42 | 1211.43 | 1213.61 |
S1 | 1197.64 | 1199.11 | 1211.74 | 1199.66 | 1204.03 |
S2 | 1180.82 | 1192.13 | 1209.02 | 1181.83 | - |
S3 | 1168.04 | 1180.82 | 1206.31 | - | - |
Key Metrics
EPS
57.64
P/E
21.06
P/B
3.76
Dividend Yield
0.66%
Market Cap
1,01,332 Cr.
Face Value
1
Book Value
322.49
ROE
21.64%
EBITDA Growth
2,389.1 Cr.
Debt/Equity
0.06
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Dr Reddys Laboratories Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 7221.8 | 7455.7 | 7314.8 | 7889.2 | 8351.8 |
PROFIT | 1482.2 | 1380.9 | 1309.8 | 1392.4 | 1255.7 |
EPS | 89.09 | 82.94 | 78.66 | 83.61 | 75.4 |
Dr Reddys Laboratories Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 5061.8 | 4330.6 | 5317.5 | 6059 | 6903.9 |
PROFIT | 1192.6 | 475.2 | 1034.8 | 1417.2 | 1882.1 |
EPS | 71.68 | 28.55 | 62.14 | 85.1 | 113 |
Profit & Loss (Figures in Rs. Crores)
Dr Reddys Laboratories Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 15353.2 | 15959 | 14490.9 | 14477.7 | 16104.9 | 18170 | 20177.4 | 22453.8 | 25691.3 | 29600.6 | |
PROFIT | 2291.79 | 2071.62 | 1252.3 | 892.34 | 1849.63 | 2030.35 | 1954.44 | 2110.85 | 4597.54 | 5512.22 | |
EPS | 26.61 | 24.71 | 15.17 | 10.99 | 23.49 | 24.38 | 23.46 | 26.23 | 54.11 | 66.88 |
Dr Reddys Laboratories Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 10262.7 | 10645.6 | 10309.1 | 9614.9 | 10797.9 | 12693.5 | 14545.8 | 15276.8 | 17424.3 | 20584.9 | |
PROFIT | 1634.01 | 1320.26 | 1406.23 | 536.19 | 1274.22 | 2948.85 | 1849.38 | 1628.89 | 2628.55 | 4284.19 | |
EPS | 18.9 | 16.11 | 16.7 | 6.83 | 15.39 | 35.35 | 26.28 | 19.51 | 31.37 | 52.06 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 83.4 | 83.3 | 83.2 | 83.2 | 83.1 | 83 | 83 | 82.9 | 85.3 | 85.2 |
Reserves Total | 28,270.5 | 23,329.7 | 19,289.3 | 17,755.2 | 15,616.3 | 13,994.1 | 12,488.6 | 12,179.2 | 12,484.5 | 9,767.9 |
Equity Application Money | -99.1 | -126.9 | -160.1 | -196.7 | -100.6 | -53.5 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 28,254.8 | 23,286.1 | 19,212.4 | 17,641.7 | 15,598.8 | 14,023.6 | 12,571.6 | 12,262.1 | 12,569.8 | 9,853.1 |
Secured Loans | 0 | 0 | 0 | 0 | 178.7 | 60.9 | 69.3 | 70.7 | 85.7 | 86.2 |
Unsecured Loans | 2,002 | 1,347.2 | 3,384.5 | 3,030.8 | 2,031.5 | 3,777.2 | 5,002.1 | 4,847.8 | 3,266.4 | 4,227.9 |
Total Debt | 2,002 | 1,347.2 | 3,384.5 | 3,030.8 | 2,210.2 | 3,838.1 | 5,071.4 | 4,918.5 | 3,352.1 | 4,314.1 |
Other Liabilities | 337.9 | 223.1 | 192.7 | 212.5 | 280 | 297.4 | 375 | 427.6 | 344.5 | 351.2 |
Total Liabilities | 30,594.7 | 24,856.4 | 22,789.6 | 20,885 | 18,089 | 18,159.1 | 18,018 | 17,608.2 | 16,266.4 | 14,518.4 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 28,062.2 | 25,567.1 | 23,096.4 | 18,555.7 | 16,108.2 | 14,998.6 | 17,436.3 | 15,932.4 | 15,019.7 | 12,573.6 |
Less: Accumulated Depreciation | 17,636.6 | 16,348 | 14,974.9 | 10,350 | 9,257.9 | 7,807.6 | 10,468.3 | 9,001.7 | 8,456.7 | 7,196.6 |
Net Block | 10,425.6 | 9,219.1 | 8,121.5 | 8,205.7 | 6,850.3 | 7,191 | 6,968 | 6,930.7 | 6,563 | 5,377 |
Capital Work in Progress | 1,419.3 | 1,030.1 | 1,293.4 | 1,565.1 | 1,535.1 | 2,933.5 | 3,470.5 | 3,324.5 | 772.2 | 529 |
Investments | 4,930.5 | 4,985.8 | 2,615.9 | 2,211.8 | 2,677.8 | 2,587.1 | 2,298.3 | 2,109.7 | 3,833.1 | 2,247.8 |
Inventories | 6,355.2 | 4,867 | 5,088.4 | 4,541.2 | 3,506.7 | 3,357.9 | 2,908.9 | 2,852.8 | 2,557.9 | 2,569.9 |
Sundry Debtors | 8,029.8 | 7,248.5 | 6,676.4 | 4,964.1 | 5,027.8 | 3,986.9 | 4,052.7 | 3,798.6 | 4,125 | 4,101.2 |
Cash and Bank Balance | 1,727.7 | 1,730.2 | 2,419.2 | 2,078.8 | 205.3 | 222.8 | 263.8 | 386.5 | 492.1 | 1,872.4 |
Loans and Advances | 4,287.6 | 2,130.2 | 1,581 | 1,587.7 | 1,490.6 | 1,289.6 | 1,440 | 1,218.7 | 1,115.6 | 1,231 |
Total Current Assets | 20,400.3 | 15,975.9 | 15,765 | 13,171.8 | 10,230.4 | 8,857.2 | 8,665.4 | 8,256.6 | 8,290.6 | 9,774.5 |
Current Liabilities | 7,258.9 | 6,485.9 | 5,825.1 | 5,062.6 | 4,610.2 | 3,762.2 | 3,739.6 | 3,385.6 | 3,304.6 | 2,794.8 |
Provisions | 926.1 | 866.8 | 1,130.8 | 640.3 | 524.1 | 497 | 591.7 | 660.7 | 759.4 | 1,143.9 |
Total Current Liabilities & Provisions | 8,185 | 7,352.7 | 6,955.9 | 5,702.9 | 5,134.3 | 4,259.2 | 4,331.3 | 4,046.3 | 4,064 | 3,938.7 |
Net Current Assets | 12,215.3 | 8,623.2 | 8,809.1 | 7,468.9 | 5,096.1 | 4,598 | 4,334.1 | 4,210.3 | 4,226.6 | 5,835.8 |
Deferred Tax Assets | 1,057.8 | 705.2 | 1,277 | 1,068.6 | 1,219.9 | 431.7 | 540.5 | 678.4 | 590.5 | 260.5 |
Deferred Tax Liability | 84.1 | 76 | 1.4 | 28.9 | 2 | 47.3 | 195 | 162 | 53.7 | 156.2 |
Net Deferred Tax | 973.7 | 629.2 | 1,275.6 | 1,039.7 | 1,217.9 | 384.4 | 345.5 | 516.4 | 536.8 | 104.3 |
Other Assets | 630.3 | 369 | 674.1 | 393.8 | 711.8 | 465.1 | 601.6 | 516.6 | 334.7 | 424.5 |
Total Assets | 30,594.7 | 24,856.4 | 22,789.6 | 20,885 | 18,089 | 18,159.1 | 18,018 | 17,608.2 | 16,266.4 | 14,518.4 |
Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 138 | 277.57 | 102.17 | 92.17 | 190 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 83.4 | 83.3 | 83.2 | 83.2 | 83.1 | 83 | 83 | 82.9 | 85.3 | 85.2 |
Reserves Total | 24,256.5 | 20,517.8 | 18,413.1 | 17,097.2 | 15,209.4 | 12,654.6 | 11,724.8 | 11,517.7 | 11,993.1 | 10,548.8 |
Equity Application Money | -99.1 | -126.9 | -160.1 | -196.7 | -100.6 | -53.5 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 24,240.8 | 20,474.2 | 18,336.2 | 16,983.7 | 15,191.9 | 12,684.1 | 11,807.8 | 11,600.6 | 12,078.4 | 10,634 |
Secured Loans | 0 | 0 | 0 | 0 | 19.3 | 0 | 0 | 0 | 0.9 | 1.4 |
Unsecured Loans | 792.9 | 50.8 | 2,205.4 | 1,214.5 | 1,437.6 | 1,064.6 | 2,588.8 | 2,355.2 | 3,084.2 | 3,124.7 |
Total Debt | 792.9 | 50.8 | 2,205.4 | 1,214.5 | 1,456.9 | 1,064.6 | 2,588.8 | 2,355.2 | 3,085.1 | 3,126.1 |
Other Liabilities | 114.8 | 93.1 | 94.6 | 67.9 | 84.1 | 83.2 | 84.6 | 103.4 | 123.6 | 75.3 |
Total Liabilities | 25,148.5 | 20,618.1 | 20,636.2 | 18,266.1 | 16,732.9 | 13,831.9 | 14,481.2 | 14,059.2 | 15,287.1 | 13,835.4 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 16,297.2 | 15,136.6 | 13,349.1 | 12,345 | 10,215.9 | 9,774.1 | 9,223.6 | 8,675.4 | 7,580 | 5,815.6 |
Less : Accumulated Depreciation | 8,708.1 | 7,941.3 | 7,198.6 | 6,500.7 | 5,782 | 5,091.4 | 4,506.3 | 3,833.3 | 3,141.9 | 2,566.2 |
Net Block | 7,589.1 | 7,195.3 | 6,150.5 | 5,844.3 | 4,433.9 | 4,682.7 | 4,717.3 | 4,842.1 | 4,438.1 | 3,249.4 |
Capital Work in Progress | 1,211 | 924.4 | 1,200.3 | 900.8 | 411.8 | 400.1 | 675 | 540 | 616.1 | 488.3 |
Investments | 7,320.6 | 7,440 | 4,936.7 | 4,649.2 | 5,485.5 | 3,933.5 | 3,636.5 | 3,101.9 | 5,076.1 | 3,862.3 |
Inventories | 4,018.9 | 3,043 | 3,347.8 | 2,819.7 | 2,190.4 | 2,015.6 | 1,856.8 | 1,809.7 | 1,699.6 | 1,723.3 |
Sundry Debtors | 4,623.9 | 4,288.9 | 4,945.4 | 4,080 | 4,638.7 | 3,717.7 | 4,203.8 | 4,405.4 | 3,889.5 | 4,711.7 |
Cash and Bank Balance | 1,216.9 | 645.8 | 2,030.5 | 1,646.5 | 39.2 | 113.2 | 120.7 | 66.8 | 202.1 | 901.4 |
Loans and Advances | 3,838.3 | 1,512.8 | 1,255.2 | 1,141 | 1,120 | 972.3 | 1,174.4 | 1,012.8 | 1,121.9 | 964.7 |
Total Current Assets | 13,698 | 9,490.5 | 11,578.9 | 9,687.2 | 7,988.3 | 6,818.8 | 7,355.7 | 7,294.7 | 6,913.1 | 8,301.1 |
Current Liabilities | 4,399.4 | 4,112.3 | 3,537.2 | 3,064.8 | 2,535.6 | 2,175.4 | 2,445.7 | 2,179.6 | 2,127.5 | 1,952.1 |
Provisions | 395.3 | 305.2 | 322.2 | 298.7 | 207.3 | 184.7 | 173.4 | 208.4 | 170.6 | 539.5 |
Total Current Liabilities & Provisions | 4,794.7 | 4,417.5 | 3,859.4 | 3,363.5 | 2,742.9 | 2,360.1 | 2,619.1 | 2,388 | 2,298.1 | 2,491.6 |
Net Current Assets | 8,903.3 | 5,073 | 7,719.5 | 6,323.7 | 5,245.4 | 4,458.7 | 4,736.6 | 4,906.7 | 4,615 | 5,809.5 |
Deferred Tax Assets | 0 | 0 | 441.6 | 582.1 | 867.3 | 214.1 | 346.5 | 382.8 | 306 | 35.7 |
Deferred Tax Liability | 416.1 | 339.2 | 422.2 | 327.3 | 254.4 | 269.6 | 253.4 | 300.7 | 242.5 | 164.7 |
Net Deferred Tax | -416.1 | -339.2 | 19.4 | 254.8 | 612.9 | -55.5 | 93.1 | 82.1 | 63.5 | -129 |
Other Assets | 540.6 | 324.6 | 609.8 | 293.3 | 543.4 | 412.4 | 622.7 | 586.4 | 478.3 | 554.9 |
Total Assets | 25,148.5 | 20,618.1 | 20,636.2 | 18,266.1 | 16,732.9 | 13,831.9 | 14,481.2 | 14,059.2 | 15,287.1 | 13,835.4 |
Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 316.2 | 305.37 | 102.17 | 92.17 | 1,231.9 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 7,201 |
Depreciation | 1,470 |
Interest (Net) | -56.7 |
Dividend Received | 44.5 |
P/L on Sales of Assets | -90 |
Prov. and W/O (Net) | 384.1 |
P/L in Forex | -53.3 |
Total Adjustments (PBT and Ext... | 1,365.2 |
Operating Profit before Workin... | 8,566.2 |
Trade and 0ther Receivables | -805.4 |
Inventories | -1,844.5 |
Trade Payables | 346 |
Total Adjustments (OP before W... | -2,018.2 |
Cash Generated from/(used in) ... | 6,548 |
Direct Taxes Paid | -2,004.7 |
Total Adjustments(Cash Generat... | -2,004.7 |
Cash Flow before Extraordinary... | 4,543.3 |
Net Cash from Operating Activi... | 4,543.3 |
Purchased of Fixed Assets | -2,743.5 |
Sale of Fixed Assets | 108.5 |
Purchase of Investments | -14,550 |
Sale of Investments | 12,978.4 |
Interest Received | 133.8 |
Net Cash used in Investing Act... | -4,034.2 |
Proceeds from Issue of shares ... | 80.5 |
Proceed from 0ther Long Term B... | 380 |
Proceed from Short Tem Borrowi... | 549.3 |
Of the Long Tem Borrowings | -380 |
Of Financial Liabilities | -114.7 |
Dividend Paid | -664.8 |
Interest Paid | -226.6 |
Net Cash used in Financing Act... | -376.3 |
Net Profit before Tax and Extr... | 5,791.3 |
Depreciation | 975.6 |
Interest (Net) | -282.8 |
Dividend Received | 44.6 |
Prov. and W/O (Net) | 284.8 |
P/L in Forex | 7.6 |
Total Adjustments (PBT and Ext... | 602 |
Operating Profit before Workin... | 6,393.3 |
Trade and 0ther Receivables | -348.1 |
Inventories | -1,217 |
Trade Payables | 280.3 |
Total Adjustments (OP before W... | -1,624.1 |
Cash Generated from/(used in) ... | 4,769.2 |
Direct Taxes Paid | -1,319.5 |
Total Adjustments(Cash Generat... | -1,319.5 |
Cash Flow before Extraordinary... | 3,449.7 |
Net Cash from Operating Activi... | 3,449.7 |
Purchased of Fixed Assets | -1,593.6 |
Sale of Fixed Assets | 88.2 |
Purchase of Investments | -13,757.8 |
Sale of Investments | 11,746.8 |
Interest Received | 182.3 |
Loans to Subsidiaires | -60.6 |
Acquisition of Companies | -80.2 |
Net Cash used in Investing Act... | -3,428.7 |
Proceeds from Issue of shares ... | 80.5 |
Proceed from Short Tem Borrowi... | 709.4 |
Of Financial Liabilities | -23.7 |
Dividend Paid | -664.8 |
Interest Paid | -33.3 |
Net Cash used in Financing Act... | 68.1 |
Company Details
Registered Office |
|
Address | 8-2-337 Road No 3, Banjara Hills |
City | Hyderabad |
State | Telangana |
Pin Code | 500034 |
Tel. No. | 91-40-49002900 |
Fax. No. | 91-40-49002999 |
shares@drreddys.com; mail@drreddys.com | |
Internet | http://www.drreddys.com |
Registrars |
|
Address | 8-2-337 Road No 3 |
City | Hyderabad |
State | Telangana |
Pin Code | 500034 |
Tel. No. | 91-40-49002900 |
Fax. No. | 91-40-49002999 |
shares@drreddys.com; mail@drreddys.com | |
Internet | http://www.drreddys.com |
Management |
|
Name | Designation |
G V Prasad | Co-Chairman & Managing Directo |
K Satish Reddy | Executive Chairman |
Shikha Sanjaya Sharma | Independent Director |
Leo Puri | Lead Independent Director |
K P Krishnan | Independent Director |
Pennv Wan | Independent Director |
K Randhir Singh | Company Sec. & Compli. Officer |
Arun M. Kumar | Independent Director |
Claudio Albrecht | Independent Director |
Sanjiv Mehta | Independent Director |
Alpna Seth | Independent Director |